Zepbound and Retatrutide News: Lilly Q4 Earnings Call Recap

Dave Knapp breaks down what the Q4 Eli Lilly earnings call means for patients living with obesity.

https://www.onthepen.com/post/lilly-s-earnings-call-could-reveal-big-changes-for-zepbound-retatrutide-what-they-ve-said-and-wha

Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp
📱 Amazon Kindle Reader: https://amzn.to/4gAXrz4
📖Paperback: https://amzn.to/4gAXrz4

💊 Peptide Supplement I Use: https://integrativepeptides.com/AFFILITATES/OTP
USE CODE "OTP10" to save 10%.

SOCIALS:
📸 : https://www.instagram.com/onthepen.official/profilecard/?igsh=dTRhY3JkYWo1bTIx
🇨🇳: https://www.tiktok.com/@manonthemounjaro?_t=ZP-8sr5PrUuPQl&_r=1
👾: https://discord.gg/ZHeUh7WV
📺: https://youtube.com/@ManOnTheMounjaro?feature=shared
❌: https://x.com/manonthepen?s=21
💻: https://www.onthepen.com